New Cardiovascular Guidelines Emphasize That Fewer Steps Can Still Protect Your Heart

A recent scientific statement published in the Journal of the American College of Cardiology provides refreshed guidance on how clinicians can tailor physical activity recommendations to individual patients. Developed by a multidisciplinary writing committee convened in April 2026, the report synthesizes existing clinical and observational evidence to support both cardiovascular disease prevention and the management of established conditions.

Cardiorespiratory fitness, defined as the ability of the heart and lungs to supply oxygen to working muscles during exercise, remains an exceptionally powerful predictor of long-term survival. The authors of the statement noted that cardiorespiratory fitness associations with survival equal or exceed conventional clinical risk factors such as hypertension, hyperlipidemia, and diabetes. Despite this strong prognostic value, structured exercise counseling remains underused in standard cardiology care, often complicated by uncertainty regarding exercise safety and testing protocols.

To help bridge this implementation gap, the American College of Cardiology statement outlines practical recommendations organized around the FITT principle, which covers frequency, intensity, time, and type of activity. Key recommendations from the multidisciplinary committee include:

• Healthy adults and those with stable chronic cardiovascular disease should aim for at least 150 minutes of moderate-intensity aerobic activity or 75 minutes of vigorous activity weekly.
• Activity volume can also be targeted at 500 to 1,000 metabolic equivalent of task minutes per week.
• Resistance training should be performed at least twice weekly alongside aerobic exercise to help preserve lean muscle mass and improve metabolic health.
• Older adults experiencing frailty should prioritize initial training focused on strength, balance, mobility, and flexibility before advancing to endurance workouts.

Notably, the statement highlights that achieving massive step counts is not an absolute prerequisite for meaningful health gains. Citing a meta-analysis included in the report, the authors reported that taking approximately 7,000 steps daily was associated with a 47 percent lower risk of all-cause and cardiovascular mortality when compared to taking only 2,000 steps daily. The findings reinforce that the greatest absolute reductions in cardiovascular risk often occur when previously inactive individuals transition to becoming modestly active.

The guidance also details specific exercise approaches for various patient populations, such as supervised walking therapy for individuals with symptomatic peripheral artery disease and intermittent claudication. For patients with heart failure with reduced ejection fraction, cited data from the HF-ACTION trial associated structured exercise with an 11 percent lower combined risk of death or hospitalization after adjusting for baseline clinical characteristics. However, the committee noted that while exercise improves functional capacity and quality of life in heart failure with preserved ejection fraction, its direct effect on major clinical events remains uncertain.

Regarding clinical evaluation, the authors clarified that routine maximal exercise testing is generally unnecessary for most asymptomatic or clinically stable individuals, as false-positive outcomes can sometimes discourage people from starting exercise regimens. Furthermore, the writing committee cautioned that weekly physical activity does not fully offset the cardiovascular risks associated with prolonged sitting, and that commercial wearable devices—while helpful for real-time biometric feedback—can vary in efficacy and may introduce digital access disparities.